tiprankstipranks
Trending News
More News >

Theriva Biologics Sets 2025 Shareholder Meeting Date

Story Highlights
Theriva Biologics Sets 2025 Shareholder Meeting Date

Don’t Miss TipRanks’ Half-Year Sale

Theriva Biologics ( (TOVX) ) just unveiled an announcement.

Theriva Biologics, Inc. announced the date for its 2025 Annual General Meeting of Shareholders, set for August 29, 2025. The company has revised deadlines for stockholder proposals and director nominations due to the meeting being scheduled more than 30 days prior to the anniversary of the previous year’s meeting. Proposals to be included in the proxy materials must be submitted by July 5, 2025, and stockholders intending to solicit proxies for director nominees must also comply with the new deadline.

The most recent analyst rating on (TOVX) stock is a Buy with a $6.00 price target. To see the full list of analyst forecasts on Theriva Biologics stock, see the TOVX Stock Forecast page.

Spark’s Take on TOVX Stock

According to Spark, TipRanks’ AI Analyst, TOVX is a Neutral.

Theriva Biologics faces substantial financial difficulties with no revenue and growing losses, which is a major concern. While technical indicators show some short-term positive momentum, the long-term trend remains negative. The lack of profitability impacts valuation. However, the recent positive clinical trial results provide a potential future catalyst that could improve the company’s prospects.

To see Spark’s full report on TOVX stock, click here.

More about Theriva Biologics

Average Trading Volume: 1,414,492

Technical Sentiment Signal: Strong Sell

Current Market Cap: $3.89M

For a thorough assessment of TOVX stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1